Year archive

Arctic Bioscience — 2021 filings

All 53 regulatory filings released by Arctic Bioscience (ABS) in 2021, sourced directly from the official regulator.

53 Filings

2021 Period

2021 filings (53)

Filing	Released	Lang
Arctic Bioscience - Presentation at DNB Healthcare Conference 2021 Investor Presentation	2021-12-16	English
Arctic Bioscience - Presentation at DNB Healthcare Conference 2021 Investor Presentation	2021-12-16	English
Arctic Bioscience Q3 2021 Operational Update Interim / Quarterly Report Q3 2021	2021-11-18	English
Arctic Bioscience Q3 2021 Operational Update Interim / Quarterly Report Q3 2021	2021-11-18	English
Arctic Bioscience - Strengthening IP platform with new patent for method for utilizing immature herring roe Regulatory Filings	2021-11-16	English
Arctic Bioscience: Minutes from EGM - Marita Holstad elected to Board AGM Information	2021-11-10	English
Arctic Bioscience: Minutes from EGM - Marita Holstad elected to Board AGM Information	2021-11-10	English
Arctic Bioscience: Minutes from EGM - Marita Holstad elected to Board AGM Information	2021-11-10	English
Arctic Bioscience AS - Notice of extraordinary general meeting - new date AGM Information	2021-10-25	Norwegian
Arctic Bioscience AS - Notice of extraordinary general meeting - new date AGM Information	2021-10-25	English
Arctic Bioscience AS - Notice of extraordinary general meeting: Marita Holstad proposed as new board member AGM Information	2021-10-19	Norwegian
Arctic Bioscience AS - Notice of extraordinary general meeting: Marita Holstad proposed as new board member Board/Management Information	2021-10-19	English
Arctic Bioscience H1 2021 results: phase IIb study on track and revenue up 50% y/y Interim / Quarterly Report H1 2021	2021-08-26	English
Arctic Bioscience H1 2021 results: phase IIb study on track and revenue up 50% y/y Investor Presentation	2021-08-26	English
Arctic Bioscience H1 2021 results: phase IIb study on track and revenue up 50% y/y Interim / Quarterly Report H1 2021	2021-08-26	English
Arctic Bioscience H1 2021 results: phase IIb study on track and revenue up 50% y/y Earnings Release H1 2021	2021-08-26	English
Arctic Bioscience AS: Invitation to Presentation of H1 2021 Results Report Publication Announcement	2021-08-20	English
Arctic Bioscience - PIR IV INVEST to distribute shares in Arctic Bioscience to fund investors Delisting Announcement	2021-07-12	English
Arctic Bioscience - PIR IV INVEST to distribute shares in Arctic Bioscience to fund investors Share Issue/Capital Change	2021-07-12	English
Arctic Bioscience awarded grant from The Research Council of Norway for its pharmaceutical development Capital/Financing Update	2021-06-17	Norwegian
Arctic Bioscience awarded grant from The Research Council of Norway for its pharmaceutical development Regulatory Filings	2021-06-17	English
Arctic Bioscience Q1 Company Update Interim / Quarterly Report Q1 2021	2021-05-31	English
Arctic Bioscience Q1 Company Update Interim / Quarterly Report Q1 2021	2021-05-31	English
Arctic Bioscience - Presentation at ABG Sundal Collier Life Science Summit Investor Presentation	2021-05-25	English
Arctic Bioscience - Presentation at ABG Sundal Collier Life Science Summit Investor Presentation	2021-05-25	English
New drug candidate for normal brain development in extremely premature infants Regulatory Filings	2021-05-20	English
New drug candidate for normal brain development in extremely premature infants Regulatory Filings	2021-05-20	English
New drug candidate for normal brain development in extremely premature infants Regulatory Filings	2021-05-20	English
New drug candidate for normal brain development in extremely premature infants Regulatory Filings	2021-05-20	English
Arctic Bioscience AS - End of stabilization Transaction in Own Shares	2021-03-24	English
Arctic Bioscience AS - End of stabilization Share Issue/Capital Change	2021-03-24	English
Arctic Bioscience AS - End of stabilization Share Issue/Capital Change	2021-03-24	English
Arctic Bioscience AS – Stabilization notice Share Issue/Capital Change	2021-03-18	English
Arctic Bioscience AS – Stabilization notice Transaction in Own Shares	2021-03-18	English
Arctic Bioscience AS – Stabilization notice Capital/Financing Update	2021-03-18	English
Arctic Bioscience: New company presentation Investor Presentation	2021-03-10	English
Arctic Bioscience: New company presentation Report Publication Announcement	2021-03-10	English
Arctic Bioscience AS – Stabilization measures taken Transaction in Own Shares	2021-03-09	Norwegian
Arctic Bioscience AS – Stabilization measures taken Share Issue/Capital Change	2021-03-09	Norwegian
Arctic Bioscience AS – Stabilization measures taken Share Issue/Capital Change	2021-03-09	English
Arctic Bioscience signerer 3-årig avtale på 75 millioner kroner med Smerud Medical Research International for å gjennomføre klinisk studie på psoriasis Regulatory Filings	2021-03-03	Norwegian
Arctic Bioscience Signs 3-year Agreement Worth 75 Million NOK with Smerud Medical Research International to Conduct Clinical Study on Psoriasis Regulatory Filings	2021-03-03	English
Obligatorisk melding om handel av nærstående av primærinnsider Director's Dealing	2021-02-26	Norwegian
Mandatory Notification of Trade by Close Associate of Primary Insider Director's Dealing	2021-02-26	English
Arctic Bioscience AS: Stabilisation and over-allotment notice Capital/Financing Update	2021-02-24	English
Arctic Bioscience AS – Information document Capital/Financing Update	2021-02-24	English
Arctic Bioscience AS – Information document Regulatory Filings	2021-02-24	English
Finansiell kalender Report Publication Announcement	2021-02-23	Norwegian
Financial calendar Report Publication Announcement	2021-02-23	English
Euronext Growth - Received application for admission to trading – Arctic Bioscience AS Regulatory Filings	2021-02-23	English
Euronext Growth - Mottatt søknad om opptak til handel – Arctic Bioscience AS Regulatory Filings	2021-02-23	Norwegian
Arctic Bioscience AS: NOK 300 million Private Placement successfully placed Capital/Financing Update	2021-02-19	English
Arctic Bioscience announces private placement and intention to list on Euronext Growth Oslo Capital/Financing Update	2021-02-16	English